Daiwa Securities Group
TARO

Daiwa Securities Group’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Daiwa Securities Group’s Portfolio TARO Stock Details TARO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-300
Closed -$34K – 1037
2017
Q3 		$34K Hold
300
– – ﹤0.01% 960
2017
Q2 		$34K Hold
300
– – ﹤0.01% 974
2017
Q1 		$35K Hold
300
– – ﹤0.01% 953
2016
Q4 		$32K Hold
300
– – ﹤0.01% 989
2016
Q3 		$33K Hold
300
– – ﹤0.01% 903
2016
Q2 		$44K Buy
+300
New +$42.5K ﹤0.01% 879

Other funds holding TARO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
MICM
Matthews International Capital Management San Francisco, California $246M AUM 10.45% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
AL
AJO LP Philadelphia, Pennsylvania $199M AUM 109.68% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
FL
Fort LP Chevy Chase, Maryland $39.6M AUM 37.11% 1-Year Est. Return

Daiwa Securities Group's TARO Position: Q4 2017 in Review

Daiwa Securities Group sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q4 2017, closing a stake of 300 shares — an estimated $34K sold.

Daiwa Securities Group first reported a position in TARO in Q2 2016 and held it in 6 quarters. The position peaked at $44K in Q2 2016. 127 funds tracked by Wall St. Rank hold TARO as of Q4 2017.

  • Daiwa Securities Group reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q4 2017 after selling out during the quarter.
  • Daiwa Securities Group sold 300 Taro Pharmaceutical Industries Ltd. shares in Q4 2017, an estimated $34K.
  • Daiwa Securities Group first reported a position in Taro Pharmaceutical Industries Ltd. in Q2 2016 and held it in 6 quarters.
  • Daiwa Securities Group's Taro Pharmaceutical Industries Ltd. position peaked at $44K in Q2 2016.
  • 127 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q4 2017.

Based on Daiwa Securities Group's 13F filing for Q4 2017, filed 6 Feb 2018.